Since glucocorticoid challenge enhances the DUSP-1 gene expression and reduces production of inflammatory mediators [18]it may perhaps explain the improvement of the quality of life scores for most CRSwNP individuals, especially those with low baseline expression of DUSP-1. The gene discussed is DUSP1; the disease is chronic rhinosinusitis with nasal polyps.